GE HealthCare Technologies
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
Track GE HealthCare Technologies in real time with a live news feed covering GE HealthCare Technologies stock news, official press releases, company announcements, and an archive of historical GE HealthCare Technologies news. ...more
Loading news...
Loading more...
8:51 AM | Thursday | Jul 30, 2026
Sign in to download news snippet
GE HealthCare Technologies is upgraded to Buy, driven by robust 11% YoY orders growth, a record $23.9B backlog, and strong forward visibility. GEHC's demand strength is structural, with AI-enabled imaging and theranostics innovation expected to accelerate revenue and margin expansion into 2027 and beyond. The Patient Care Solutions segment is a temporary drag due to supply chain issues, but backlog and demand remain intact, positioning for recovery as constraints ease.
Read full articleNo data available for this time period.
Change the time range to see results.
GE HealthCare Technologies is upgraded to Buy, driven by robust 11% YoY orders growth, a record $23.9B backlog, and strong forward visibility. GEHC's demand strength is structural, with AI-enabled imaging and theranostics innovation expected to accelerate revenue and margin expansion into 2027 and beyond. The Patient Care Solutions segment is a temporary drag due to supply chain issues, but backlog and demand remain intact, positioning for recovery as constraints ease.
Read full article
Shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC - Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $64.11, but opened at $69.32.
GE HealthCare Technologies shares last traded at $71.8030, with a volume of 2,822,886 shares. The company reported $1.13
GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.
Read full article
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript
Read full article
Order growth and backlog signal potential revenue and margin improvements. Management expects cost actions and new products to boost margins in the coming years.
Read full article
Stocks are selling off today, as Wall Street wrangles with the return of Middle East hostilities and higher oil prices
Read full article
GE HealthCare Technologies NASDAQ: GEHC reported second-quarter results marked by strong order growth, a record backlog and continued momentum in its Advanced Imaging Solutions and Pharmaceutical Diagnostics businesses, while Patient Care Solutions remained pressured by operational fulfillment issues.
Read full article
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.06 per share a year ago.
GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.
3 billion, respectively.
GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Donald Trump.
Read full article
GE HealthCare Technologies notched higher profit and revenue in the second quarter, boosted by increased orders across the business.
Read full article
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered record orders and backlog in the second quarter, with orders growth across every segment, demonstrating strong commercial execution, including the adoption of new products. In Patient Care Solutions, while we are focused on returning the business to growth and profitability, we are reviewing strategi.
Read full article
First Trust Advisors LP reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 38.4% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 440,549 shares of the company's stock after selling 275,000 shares during
Read full article
GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.
Read full article
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript
Read full article
Order growth and backlog signal potential revenue and margin improvements. Management expects cost actions and new products to boost margins in the coming years.
Read full article
GE HealthCare Technologies NASDAQ: GEHC reported second-quarter results marked by strong order growth, a record backlog and continued momentum in its Advanced Imaging Solutions and Pharmaceutical Diagnostics businesses, while Patient Care Solutions remained pressured by operational fulfillment issues.
Read full article
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.06 per share a year ago.
GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.
3 billion, respectively.
GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U.S. President Donald Trump.
Read full article
GE HealthCare Technologies notched higher profit and revenue in the second quarter, boosted by increased orders across the business.
Read full article
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered record orders and backlog in the second quarter, with orders growth across every segment, demonstrating strong commercial execution, including the adoption of new products. In Patient Care Solutions, while we are focused on returning the business to growth and profitability, we are reviewing strategi.
Read full article
First Trust Advisors LP reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 38.4% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 440,549 shares of the company's stock after selling 275,000 shares during
Read full article
No data available for this time period.
Change the time range to see results.